Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 8 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lite Strategy, Inc. | 1,601,390 | reported | 09 Dec 2014 | tx 4−279,085 |
| Relypsa Inc | 1,257,599 | reported | 20 Nov 2013 | tx 16+2,162,558−1,867,908 |
| Rallybio Corp | 14,305 | reported | 18 Feb 2026 | tx 16+2,523,286−12,696,438 |
| Durata Therapeutics, Inc. | 8,575 | reported | 21 May 2014 | tx 4+3,037,014−17,953,008 |
| CORIXA CORP | 5,000 | reported | 28 May 2004 | tx 3+3,729,085 |
| Neuronetics, Inc. | 847 | reported | 01 Apr 2019 | tx 10+1,552,729−1,543,115 |
| Iterum Therapeutics plc | 0 | reported | 13 Jan 2025 | tx 40+3,011,773−1,343,508 |
| Harpoon Therapeutics, Inc. | 0 | reported | 11 Mar 2024 | tx 46+9,596,894−5,454,970 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Feb 2026 | GRANT_AWARD | Rallybio Corp | 14,305 | 3.60 USD | deriv |
| 13 May 2025 | GRANT_AWARD | Rallybio Corp | 28,500 | 0.00 USD | deriv |
| 13 Jan 2025 | OTHER | Iterum Therapeutics plc | — | 792000.00 USD | deriv |
| 13 Jan 2025 | OTHER | Iterum Therapeutics plc | — | 2208000.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Rallybio Corp | 73,571 | 0.70 USD | deriv |
| 06 Aug 2024 | EXERCISE | Iterum Therapeutics plc | 65,481 | — | |
| 06 Aug 2024 | EXERCISE | Iterum Therapeutics plc | 182,453 | — | |
| 06 Aug 2024 | EXERCISE | Iterum Therapeutics plc | 182,453 | — | deriv |
| 06 Aug 2024 | EXERCISE | Iterum Therapeutics plc | 182,453 | — | deriv |
| 06 Aug 2024 | EXERCISE | Iterum Therapeutics plc | 364,906 | 0.00 USD | deriv |
| 06 Aug 2024 | EXERCISE | Iterum Therapeutics plc | 130,962 | 0.00 USD | deriv |
| 06 Aug 2024 | EXERCISE | Iterum Therapeutics plc | 65,481 | — | deriv |
| 06 Aug 2024 | EXERCISE | Iterum Therapeutics plc | 65,481 | — | deriv |
| 15 May 2024 | GRANT_AWARD | Rallybio Corp | 16,500 | 0.00 USD | deriv |
| 08 Mar 2024 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 424 | 0.00 USD | |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 13,224 | — | |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 1,463,386 | — | |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 395,783 | — | |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 10,000 | — | |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 85,750 | — | deriv |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 2,033 | — | deriv |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 3,214 | — | deriv |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 2,300 | — | deriv |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 686,000 | — | deriv |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 299,430 | — | deriv |
5 purchases reported after at least 12 months of silence — most recent on 23 Mar 2023.